M S Miah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
M S Miah has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
N Kernohan
Department of Pathology,Ninewells Hospital and University of Dundee Medical School,Scotland,UK
2 shared publicationsS Mahendran
Department of Otorhinolaryngology - Head and Neck Surgery,Ninewells Hospital and University of Dundee Medical School,Scotland,UK
2 shared publicationsC Kennedy
Department of Otorhinolaryngology - Head and Neck Surgery,Ninewells Hospital and University of Dundee Medical School,Scotland,UK
1 shared publicationC Mak
Department of Otorhinolaryngology - Head and Neck Surgery,Ninewells Hospital and University of Dundee Medical School,Scotland,UK
1 shared publicationD Smith
Department of General Surgery,Ninewells Hospital and University of Dundee Medical School,Scotland,UK
1 shared publicationG Leese
Department of Endocrinology,Ninewells Hospital and University of Dundee Medical School,Scotland,UK
1 shared publication
Latest Publications
- 1 March 2015
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 129 (11) , 1128-1132
Pre-operative serum alkaline phosphatase as a predictive indicator of post-operative hypocalcaemia in patients undergoing total thyroidectomy
Objective: This study aimed to evaluate whether a pre-operative elevated serum alkaline phosphatase level is a potential predictor of post-operative hypocalcaemia after total thyroidectomy.Methods: Data was retrospectively collected from the case notes of patients who had undergone total thyroidectomy. Patients were divided into Graves’ disease and non-Graves’ groups. Pre-operative and post-operative biochemical markers, including serum calcium, alkaline phosphatase and parathyroid hormone levels, were reviewed.Results: A total of 225 patients met the inclusion criteria. Graves’ disease was the most common indication (n= 134; 59.5 per cent) for thyroidectomy. Post-operative hypocalcaemia developed in 48 patients (21.3 per cent) and raised pre-operative serum alkaline phosphatase was noted in 94 patients (41.8 per cent). Raised pre-operative serum alkaline phosphatase was significantly associated with post-operative hypocalcaemia, particularly in Graves’ disease patients (p<0.05).Conclusion: Pre-operative serum alkaline phosphatase measurements help to predict post-thyroidectomy hypocalcaemia, especially in patients who do not develop hypoparathyroidism. Ascertaining the pre-operative serum alkaline phosphatase level in patients undergoing total thyroidectomy may help surgeons to identify at-risk patients.
- 1 March 2015
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 129 (11) , 1128-1132
Pre-operative serum alkaline phosphatase as a predictive indicator of post-operative hypocalcaemia in patients undergoing total thyroidectomy
Objective: This study aimed to evaluate whether a pre-operative elevated serum alkaline phosphatase level is a potential predictor of post-operative hypocalcaemia after total thyroidectomy.Methods: Data was retrospectively collected from the case notes of patients who had undergone total thyroidectomy. Patients were divided into Graves’ disease and non-Graves’ groups. Pre-operative and post-operative biochemical markers, including serum calcium, alkaline phosphatase and parathyroid hormone levels, were reviewed.Results: A total of 225 patients met the inclusion criteria. Graves’ disease was the most common indication (n= 134; 59.5 per cent) for thyroidectomy. Post-operative hypocalcaemia developed in 48 patients (21.3 per cent) and raised pre-operative serum alkaline phosphatase was noted in 94 patients (41.8 per cent). Raised pre-operative serum alkaline phosphatase was significantly associated with post-operative hypocalcaemia, particularly in Graves’ disease patients (p<0.05).Conclusion: Pre-operative serum alkaline phosphatase measurements help to predict post-thyroidectomy hypocalcaemia, especially in patients who do not develop hypoparathyroidism. Ascertaining the pre-operative serum alkaline phosphatase level in patients undergoing total thyroidectomy may help surgeons to identify at-risk patients.
- 1 March 2015
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 129 (10) , 1000-1003
Human papillomavirus and salivary gland neoplasia: a p16INK4immunohistochemical and in situ hybridisation study
Objective:This study aimed to evaluate the association between human papillomavirus infection and salivary gland tumours in a Scottish cohort.Methods:Specimens from a range of salivary gland tumours operated on between 1997 and 2012 were studied. A tissue microarray constructed from tissue blocks was subjected to p16INK4 (cyclin-dependent kinase inhibitor 2A) immunohistochemistry and in situ hybridisation using probes specific for human papillomavirus, including types 16 and 18.Results:A total of 61 tumours (benign and malignant) were deemed suitable for the study. p16INK4 staining yielded three (4.9 per cent) positive samples: one small cell carcinoma, one squamous cell carcinoma and one poorly differentiated carcinoma. Human papillomavirus in situ hybridisation demonstrated a positive signal in the latter sample only (1.6 per cent).Conclusion:This study demonstrated a very low human papillomavirus detection rate in salivary gland tumours. It can therefore be concluded that human papillomavirus infection is unlikely to play a role in salivary gland neoplasia. Rare human papillomavirus positive cases should be carefully evaluated to exclude the possibility of a metastatic lesion.
- 1 March 2015
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 129 (10) , 1000-1003
Human papillomavirus and salivary gland neoplasia: a p16INK4immunohistochemical and in situ hybridisation study
Objective:This study aimed to evaluate the association between human papillomavirus infection and salivary gland tumours in a Scottish cohort.Methods:Specimens from a range of salivary gland tumours operated on between 1997 and 2012 were studied. A tissue microarray constructed from tissue blocks was subjected to p16INK4 (cyclin-dependent kinase inhibitor 2A) immunohistochemistry and in situ hybridisation using probes specific for human papillomavirus, including types 16 and 18.Results:A total of 61 tumours (benign and malignant) were deemed suitable for the study. p16INK4 staining yielded three (4.9 per cent) positive samples: one small cell carcinoma, one squamous cell carcinoma and one poorly differentiated carcinoma. Human papillomavirus in situ hybridisation demonstrated a positive signal in the latter sample only (1.6 per cent).Conclusion:This study demonstrated a very low human papillomavirus detection rate in salivary gland tumours. It can therefore be concluded that human papillomavirus infection is unlikely to play a role in salivary gland neoplasia. Rare human papillomavirus positive cases should be carefully evaluated to exclude the possibility of a metastatic lesion.
- 1 March 2015
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 129 (8) , 801-806
p16 status and interval neck dissection findings after a ‘clinically complete response’ to chemoradiotherapy in oropharyngeal squamous cell carcinoma
Objectives:To evaluate the histopathological findings from post-treatment neck dissection of p16 positive and negative oropharyngeal carcinoma cases, after completion of chemoradiotherapy, and to question the role of neck dissection after a ‘clinically complete response’ to chemoradiotherapy.Methods:Data were collected retrospectively from a cohort of patients treated with curative intent using chemoradiotherapy and post-treatment neck dissection. Primary tumours underwent p16 immunohistochemistry. Neck dissection specimens were examined for viable cancer cells.Results:A total of 76 cases were assessed. Viable cancer cells were detected from neck dissection in 29 per cent of p16 negative cases. Locoregional recurrence occurred in 12.9 per cent of p16 negative cases. The association between p16 positivity in the primary tumour and histopathologically negative neck dissection was significant (p < 0.05).Conclusion:p16 status appeared to be an independent marker of disease control for the cohort in this study. The data raise questions about the role of post-treatment neck dissection in p16 positive cases with a ‘clinically complete response’ to chemoradiotherapy.
- 1 March 2015
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 129 (8) , 801-806
p16 status and interval neck dissection findings after a ‘clinically complete response’ to chemoradiotherapy in oropharyngeal squamous cell carcinoma
Objectives:To evaluate the histopathological findings from post-treatment neck dissection of p16 positive and negative oropharyngeal carcinoma cases, after completion of chemoradiotherapy, and to question the role of neck dissection after a ‘clinically complete response’ to chemoradiotherapy.Methods:Data were collected retrospectively from a cohort of patients treated with curative intent using chemoradiotherapy and post-treatment neck dissection. Primary tumours underwent p16 immunohistochemistry. Neck dissection specimens were examined for viable cancer cells.Results:A total of 76 cases were assessed. Viable cancer cells were detected from neck dissection in 29 per cent of p16 negative cases. Locoregional recurrence occurred in 12.9 per cent of p16 negative cases. The association between p16 positivity in the primary tumour and histopathologically negative neck dissection was significant (p < 0.05).Conclusion:p16 status appeared to be an independent marker of disease control for the cohort in this study. The data raise questions about the role of post-treatment neck dissection in p16 positive cases with a ‘clinically complete response’ to chemoradiotherapy.